The use of miracidia for the screening of compounds for activity against Fasciola hepatica.
D000818:Animals; D000871:Anthelmintics / Q000494:pharmacology*; D004353:Drug Evaluation, Preclinical; D005210:Fasciola hepatica / Q000187:drug effects*; D006801:Humans; D007814:Larva / Q000187:drug effects
D000871:Anthelmintics